Antipsychotic Effects of Oxytocin
Sponsor: National Institute of Mental Health (NIMH)
Terminated
Break in funding
Other terminated trials from National Institute of Mental Health (NIMH)
- Castration-Resistant Prostate Carcinoma · Phase PHASE1 · Feb 2025
- Adolescent Depression · Phase PHASE2 · Dec 2024
- Healthy Volunteers · Phase PHASE1 · Jun 2024
- Suicidal Ideation · Phase PHASE2/PHASE3 · Jun 2024
- Depression · Phase PHASE2 · May 2024
See all terminations from National Institute of Mental Health (NIMH)
This NA trial investigates Schizophrenia and is currently terminated or withdrawn. National Institute of Mental Health (NIMH) leads this study, which shows 10 recorded versions since 2011 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Dec 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Dec 2019 — Jan 2021 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Jun 2018 — Dec 2019 [monthly]
Suspended NA
-
Feb 2017 — Jun 2018 [monthly]
Suspended NA
-
Jan 2017 — Feb 2017 [monthly]
Suspended NA
First recorded
Jun 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Mental Health (NIMH)
- University of California, San Diego
For direct contact, visit the study record on ClinicalTrials.gov .